These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 317001)

  • 21. Effects of vaccination for Marek's disease on growth of a Marek's-virus-induced transplantable lymphoma in syngeneic and allogeneic chickens.
    Schierman LW; McBride RA
    Avian Dis; 1979; 23(1):47-56. PubMed ID: 486007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of maternal immunity against development of Marek's disease and protective ability of vaccine.
    Yoshida I; Yuasa N; Horiuchi T; Tsubahara H
    Natl Inst Anim Health Q (Tokyo); 1975; 15(1):1-7. PubMed ID: 804667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibody to chicken fetal antigen on Marek's disease lymphoblastoid cell line MDCC-MSB1.
    Ohashi K; Mikami T; Higashihara T; Kodama H; Izawa H
    Cancer Res; 1986 Nov; 46(11):5858-63. PubMed ID: 2428485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent infections with Marek's disease virus and turkey herpesvirus.
    Calnek BW; Shek WR; Schat KA
    J Natl Cancer Inst; 1981 Mar; 66(3):585-90. PubMed ID: 6259403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with nononcogenic Marek's disease virus and herpesvirus of turkeys.
    Schat KA; Calnek BW
    J Natl Cancer Inst; 1978 Sep; 61(3):855-7. PubMed ID: 211242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
    Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the efficacy against Marek's disease of cell-free and cell-associated turkey herpesvirus vaccine.
    Eidson CS; Villegas P; Page RK; Kleven SH
    Avian Dis; 1975; 19(3):515-24. PubMed ID: 1164319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of genomes of both herpesvirus of turkeys and Marek's disease virus in a chicken T-lymphoblastoid cell line.
    Kitamoto N; Ikuta K; Kato S; Hirai K
    Biken J; 1980 Mar; 23(1):1-8. PubMed ID: 6254498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marek's disease tumour-specific antigen induced by the herpesvirus of turkeys in vaccinated chickens.
    Powell PC; Rennie M
    Vet Rec; 1978 Sep; 103(11):232-3. PubMed ID: 716166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-viral immunity against Marek's disease virus infected chicken kidney cells.
    Kodama H; Sugimoto C; Inage F; Mikami T
    Avian Pathol; 1979 Jan; 8(1):33-44. PubMed ID: 18770425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nature of genetic resistance to Marek's disease in chickens.
    Lee LF; Powell PC; Rennie M; Ross LJ; Payne LN
    J Natl Cancer Inst; 1981 Apr; 66(4):789-96. PubMed ID: 6262555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of natural killer cells in specific-pathogen-free chickens.
    Sharma JM; Coulson BD
    J Natl Cancer Inst; 1979 Aug; 63(2):527-31. PubMed ID: 156805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenicity of a Marek's disease virus for chickens vaccinated with graded doses of herpesvirus of turkeys.
    Cauchy L; Coudert F; Dambrine G
    Avian Dis; 1979; 23(4):821-30. PubMed ID: 546406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination against Marek's disease with cell-free turkey herpesvirus: interference by maternal antibody.
    Calnek W; Smith MW
    Avian Dis; 1972; 16(4):954-7. PubMed ID: 5079883
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine.
    Sharma JM
    Avian Dis; 1984; 28(3):629-40. PubMed ID: 6091603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depression of in vitro responsiveness to phytohemagglutinin in spleen cells cultured from chickens with Marek's disease.
    Theis GA; McBride RA; Schierman LW
    J Immunol; 1975 Sep; 115(3):848-53. PubMed ID: 168267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.